Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GeneDx Holdings (WGS) Other Non Operating Income (2020 - 2026)

GeneDx Holdings has reported Other Non Operating Income over the past 7 years, most recently at -$6.6 million for Q1 2026.

  • Quarterly Other Non Operating Income fell 3241.15% to -$6.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$11.1 million through Mar 2026, up 13.63% year-over-year, with the annual reading at -$4.3 million for FY2025, 66.83% up from the prior year.
  • Other Non Operating Income was -$6.6 million for Q1 2026 at GeneDx Holdings, down from -$4.6 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $2.7 million in Q1 2023 and troughed at -$13.5 million in Q2 2024.
  • The 5-year median for Other Non Operating Income is $500.0 (2022), against an average of -$1.4 million.
  • Year-over-year, Other Non Operating Income crashed 56800.0% in 2023 and then soared 464.86% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at -$1000.0 in 2022, then plummeted by 4800.0% to -$49000.0 in 2023, then tumbled by 1357.14% to -$714000.0 in 2024, then plummeted by 543.0% to -$4.6 million in 2025, then tumbled by 43.0% to -$6.6 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Other Non Operating Income are -$6.6 million (Q1 2026), -$4.6 million (Q4 2025), and -$174000.0 (Q3 2025).